loadpatents
Patent applications and USPTO patent grants for CHA; Edward Namserk.The latest application filed is for "methods for treatment of cancer with an anti-tigit antagonist antibody".
Patent | Date |
---|---|
Methods For Treatment Of Cancer With An Anti-tigit Antagonist Antibody App 20220016243 - LAI; Catherine ;   et al. | 2022-01-20 |
Treatment With Anti-tigit Antibodies And Pd-1 Axis Binding Antagonists App 20210395366 - LI; Shi ;   et al. | 2021-12-23 |
Combination Therapy For Cancer Comprising Pd-1 Axis Binding Antagonist And Il6 Antagonist App 20210332143 - Huseni; Mahrukh ;   et al. | 2021-10-28 |
Treatment Of Triple Negative Breast Cancer Or Colorectal Cancer With Liver Metastases With An Anti Pd-l1 Antibody And An Oncolyt App 20200254037 - Kind Code | 2020-08-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.